세계의 항생제 의약품 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)
Antibiotic Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1872326
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 항생제 의약품 시장 규모는 2024년에 525억 5,200만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 3.2%로 성장하여 2031년까지 658억 3,300만 달러로 확대될 것으로 예측됩니다.
항생제는 세균의 증식을 억제하거나 살균하여 세균 감염증의 예방 및 치료에 사용되는 약제군입니다. 박테리아의 생존과 증식에 필수적인 세포벽, 단백질 합성, DNA 복제 등 특정 구성요소를 표적으로 작용합니다. 항생제는 폐렴, 요로감염증, 피부감염증, 결핵 등 감염성 질환의 치료에 널리 사용되고 있습니다. 감염의 정도와 부위에 따라 경구용 정제, 정맥주사, 외용 크림 등 다양한 형태로 투여됩니다. 항생제는 현대 의학의 근간이 되어 세균 감염을 제어함으로써 수많은 생명을 구해왔습니다.
항생제 시장은 특히 의료 접근성이 제한된 개발도상국에서 전 세계적으로 세균 감염에 대한 부담이 증가함에 따라 항생제 시장이 주도하고 있습니다. 항생제는 호흡기 감염과 같은 가벼운 질환부터 패혈증, 결핵과 같은 심각한 질환에 이르기까지 다양한 감염성 질환의 치료에 필수적입니다. 만성질환의 증가, 병원내 감염, 고령화 사회로의 진입도 항생제 수요를 증가시키고 있습니다. 또한, 신규 광범위 항생제 개발 및 새로운 전달 시스템 도입 등 제제 기술의 발전으로 새로운 내성균주에 대한 대응이 가능해져 시장 성장을 더욱 촉진하고 있습니다.
그러나 항생제 시장은 항생제 내성 위협의 증가로 인해 심각한 도전에 직면해 있습니다. 인간과 동물 모두에서 항생제의 과다 사용과 오남용은 내성균의 발생을 가속화하고 기존 치료의 효과를 떨어뜨릴 수 있습니다. 이러한 내성 문제로 인해 새로운 항생제 개발이 시급한 상황이지만, 과학적, 경제적 장벽으로 인해 항생제 발견 속도는 더디게 진행되고 있습니다. 높은 연구개발 비용과 규제 장벽, 다른 의약품에 비해 짧은 항생제 특허 기간도 이 분야에 대한 투자를 제한하고 있습니다. 또한, 대체 치료법에 대한 선호도 증가와 항생제 잔류물의 환경적 영향에 대한 우려도 시장 역학에 영향을 미치고 있습니다.
이 보고서는 항생제 의약품 세계 시장에 대한 종합적인 분석을 제공하는 것을 목표로 합니다. 총매출액, 주요 기업의 기업 점유율과 순위를 중심으로 지역별, 국가별, 종류별, 용도별 항생제 분석을 게재하고 있습니다.
이 보고서는 2024년을 기준 연도로 하여 2020년부터 2031년까지의 과거 데이터와 예측 데이터를 기반으로 항생제 의약품 시장의 규모, 추정 및 예측을 매출 수익으로 제시합니다. 정량적 분석과 정성적 분석을 통해 독자들이 비즈니스/성장 전략을 수립하고, 시장 경쟁 상황을 평가하고, 현재 시장에서의 자사 위치를 분석하여 항생제 의약품에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.
시장 세분화
기업별
GSK
Pfizer
Merck & Co
Sandoz
Sumitomo Pharma
Fresenius
AbbVie
Hailin Pharmaceuticals
Bausch Health
Southwest Pharmaceuticals
Zhuhai United Pharmaceuticals
Qilu Pharmaceuticals
China Resources Sanjiu Pharmaceuticals
Shenzhen Xinlitai Pharmaceuticals
Shanghai Modern Pharmaceuticals
North China Pharmaceuticals
Sun Pharmaceuticals
Hikma Pharmaceuticals
Shijiazhuang Pharmaceutical Group
Resun Pharmaceuticals
유형별 부문
경구제
주사제
기타
약제별 부문
β-락탐계
테트라사이클린계
매크로라이드계
아미노글리코사이드계
펩타이드
퀴놀론계
기타
용도별 부문
병원
소매 약국
기타
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSM
영문 목차
영문목차
The global market for Antibiotic Drug was estimated to be worth US$ 52552 million in 2024 and is forecast to a readjusted size of US$ 65833 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Antibiotics are a class of drugs used to prevent and treat bacterial infections by inhibiting the growth or killing bacteria. They work by targeting specific components of bacterial cells, such as cell walls, protein synthesis, or DNA replication, which are essential for bacterial survival and replication. Antibiotics are widely used in the treatment of infections like pneumonia, urinary tract infections, skin infections, and tuberculosis. They can be administered in various forms, including oral tablets, intravenous injections, and topical creams, depending on the severity and location of the infection. Over time, antibiotics have become a cornerstone of modern medicine, helping to save countless lives by controlling bacterial infections.
The antibiotics drugs market is driven by the growing global burden of bacterial infections, particularly in developing regions where access to healthcare may be limited. Antibiotics are essential for treating a wide range of infections, from minor illnesses like respiratory infections to more severe diseases such as sepsis and tuberculosis. The increasing prevalence of chronic diseases, hospital-acquired infections, and the rising geriatric population are also contributing to the demand for antibiotics. Additionally, advancements in antibiotic formulations, including the development of new broad-spectrum antibiotics and the introduction of novel delivery systems, are helping to address emerging resistant strains of bacteria, further fueling market growth.
However, the antibiotics market faces significant challenges, primarily due to the rising threat of antibiotic resistance. Overuse and misuse of antibiotics in both humans and animals have accelerated the development of resistant bacteria, which can make existing treatments less effective. This resistance has led to the urgent need for new antibiotics, yet the pace of antibiotic discovery has slowed due to scientific and economic barriers. The high cost of research and development, coupled with regulatory hurdles and the shorter patent life of antibiotics compared to other drugs, also limits the investment in this sector. Furthermore, the increasing preference for alternative treatments and concerns over the environmental impact of antibiotic residues are influencing market dynamics.
This report aims to provide a comprehensive presentation of the global market for Antibiotic Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antibiotic Drug by region & country, by Type, and by Application.
The Antibiotic Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Drug.
Market Segmentation
By Company
GSK
Pfizer
Merck & Co
Sandoz
Sumitomo Pharma
Fresenius
AbbVie
Hailin Pharmaceuticals
Bausch Health
Southwest Pharmaceuticals
Zhuhai United Pharmaceuticals
Qilu Pharmaceuticals
China Resources Sanjiu Pharmaceuticals
Shenzhen Xinlitai Pharmaceuticals
Shanghai Modern Pharmaceuticals
North China Pharmaceuticals
Sun Pharmaceuticals
Hikma Pharmaceuticals
Shijiazhuang Pharmaceutical Group
Resun Pharmaceuticals
Segment by Type
Oral
Injection
Other
Segment by Drug
B-lactams
Tetracyclines
Macrolides
Aminoglycosides
Peptides
Quinolones
Other
Segment by Application
Hospitals
Retail Pharmacy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antibiotic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antibiotic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antibiotic Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Antibiotic Drug Product Introduction
1.2 Global Antibiotic Drug Market Size Forecast (2020-2031)
1.3 Antibiotic Drug Market Trends & Drivers
1.3.1 Antibiotic Drug Industry Trends
1.3.2 Antibiotic Drug Market Drivers & Opportunity
1.3.3 Antibiotic Drug Market Challenges
1.3.4 Antibiotic Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antibiotic Drug Players Revenue Ranking (2024)
2.2 Global Antibiotic Drug Revenue by Company (2020-2025)
2.3 Key Companies Antibiotic Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antibiotic Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Antibiotic Drug
2.6 Antibiotic Drug Market Competitive Analysis
2.6.1 Antibiotic Drug Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Antibiotic Drug Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Drug as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injection
3.1.3 Other
3.2 Global Antibiotic Drug Sales Value by Type
3.2.1 Global Antibiotic Drug Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Antibiotic Drug Sales Value, by Type (2020-2031)
3.2.3 Global Antibiotic Drug Sales Value, by Type (%) (2020-2031)
4 Segmentation by Drug
4.1 Introduction by Drug
4.1.1 B-lactams
4.1.2 Tetracyclines
4.1.3 Macrolides
4.1.4 Aminoglycosides
4.1.5 Peptides
4.1.6 Quinolones
4.1.7 Other
4.2 Global Antibiotic Drug Sales Value by Drug
4.2.1 Global Antibiotic Drug Sales Value by Drug (2020 VS 2024 VS 2031)
4.2.2 Global Antibiotic Drug Sales Value, by Drug (2020-2031)
4.2.3 Global Antibiotic Drug Sales Value, by Drug (%) (2020-2031)
5 Segmentation by Application
5.1 Introduction by Application
5.1.1 Hospitals
5.1.2 Retail Pharmacy
5.1.3 Other
5.2 Global Antibiotic Drug Sales Value by Application
5.2.1 Global Antibiotic Drug Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Antibiotic Drug Sales Value, by Application (2020-2031)
5.2.3 Global Antibiotic Drug Sales Value, by Application (%) (2020-2031)
6 Segmentation by Region
6.1 Global Antibiotic Drug Sales Value by Region
6.1.1 Global Antibiotic Drug Sales Value by Region: 2020 VS 2024 VS 2031
6.1.2 Global Antibiotic Drug Sales Value by Region (2020-2025)
6.1.3 Global Antibiotic Drug Sales Value by Region (2026-2031)
6.1.4 Global Antibiotic Drug Sales Value by Region (%), (2020-2031)
6.2 North America
6.2.1 North America Antibiotic Drug Sales Value, 2020-2031
6.2.2 North America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
6.3 Europe
6.3.1 Europe Antibiotic Drug Sales Value, 2020-2031
6.3.2 Europe Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
6.4 Asia Pacific
6.4.1 Asia Pacific Antibiotic Drug Sales Value, 2020-2031
6.4.2 Asia Pacific Antibiotic Drug Sales Value by Region (%), 2024 VS 2031
6.5 South America
6.5.1 South America Antibiotic Drug Sales Value, 2020-2031
6.5.2 South America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
6.6 Middle East & Africa
6.6.1 Middle East & Africa Antibiotic Drug Sales Value, 2020-2031
6.6.2 Middle East & Africa Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
7 Segmentation by Key Countries/Regions
7.1 Key Countries/Regions Antibiotic Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031
7.2 Key Countries/Regions Antibiotic Drug Sales Value, 2020-2031
7.3 United States
7.3.1 United States Antibiotic Drug Sales Value, 2020-2031
7.3.2 United States Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
7.3.3 United States Antibiotic Drug Sales Value by Application, 2024 VS 2031
7.4 Europe
7.4.1 Europe Antibiotic Drug Sales Value, 2020-2031
7.4.2 Europe Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
7.4.3 Europe Antibiotic Drug Sales Value by Application, 2024 VS 2031
7.5 China
7.5.1 China Antibiotic Drug Sales Value, 2020-2031
7.5.2 China Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
7.5.3 China Antibiotic Drug Sales Value by Application, 2024 VS 2031
7.6 Japan
7.6.1 Japan Antibiotic Drug Sales Value, 2020-2031
7.6.2 Japan Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
7.6.3 Japan Antibiotic Drug Sales Value by Application, 2024 VS 2031
7.7 South Korea
7.7.1 South Korea Antibiotic Drug Sales Value, 2020-2031
7.7.2 South Korea Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
7.7.3 South Korea Antibiotic Drug Sales Value by Application, 2024 VS 2031
7.8 Southeast Asia
7.8.1 Southeast Asia Antibiotic Drug Sales Value, 2020-2031
7.8.2 Southeast Asia Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
7.8.3 Southeast Asia Antibiotic Drug Sales Value by Application, 2024 VS 2031
7.9 India
7.9.1 India Antibiotic Drug Sales Value, 2020-2031
7.9.2 India Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
7.9.3 India Antibiotic Drug Sales Value by Application, 2024 VS 2031
8 Company Profiles
8.1 GSK
8.1.1 GSK Profile
8.1.2 GSK Main Business
8.1.3 GSK Antibiotic Drug Products, Services and Solutions
8.1.4 GSK Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.1.5 GSK Recent Developments
8.2 Pfizer
8.2.1 Pfizer Profile
8.2.2 Pfizer Main Business
8.2.3 Pfizer Antibiotic Drug Products, Services and Solutions
8.2.4 Pfizer Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.2.5 Pfizer Recent Developments
8.3 Merck & Co
8.3.1 Merck & Co Profile
8.3.2 Merck & Co Main Business
8.3.3 Merck & Co Antibiotic Drug Products, Services and Solutions
8.3.4 Merck & Co Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.3.5 Merck & Co Recent Developments
8.4 Sandoz
8.4.1 Sandoz Profile
8.4.2 Sandoz Main Business
8.4.3 Sandoz Antibiotic Drug Products, Services and Solutions
8.4.4 Sandoz Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.4.5 Sandoz Recent Developments
8.5 Sumitomo Pharma
8.5.1 Sumitomo Pharma Profile
8.5.2 Sumitomo Pharma Main Business
8.5.3 Sumitomo Pharma Antibiotic Drug Products, Services and Solutions
8.5.4 Sumitomo Pharma Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.5.5 Sumitomo Pharma Recent Developments
8.6 Fresenius
8.6.1 Fresenius Profile
8.6.2 Fresenius Main Business
8.6.3 Fresenius Antibiotic Drug Products, Services and Solutions
8.6.4 Fresenius Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.6.5 Fresenius Recent Developments
8.7 AbbVie
8.7.1 AbbVie Profile
8.7.2 AbbVie Main Business
8.7.3 AbbVie Antibiotic Drug Products, Services and Solutions
8.7.4 AbbVie Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.7.5 AbbVie Recent Developments
8.8 Hailin Pharmaceuticals
8.8.1 Hailin Pharmaceuticals Profile
8.8.2 Hailin Pharmaceuticals Main Business
8.8.3 Hailin Pharmaceuticals Antibiotic Drug Products, Services and Solutions
8.8.4 Hailin Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.8.5 Hailin Pharmaceuticals Recent Developments
8.9 Bausch Health
8.9.1 Bausch Health Profile
8.9.2 Bausch Health Main Business
8.9.3 Bausch Health Antibiotic Drug Products, Services and Solutions
8.9.4 Bausch Health Antibiotic Drug Revenue (US$ Million) & (2020-2025)
8.9.5 Bausch Health Recent Developments
8.10 Southwest Pharmaceuticals
8.10.1 Southwest Pharmaceuticals Profile
8.10.2 Southwest Pharmaceuticals Main Business
8.10.3 Southwest Pharmaceuticals Antibiotic Drug Products, Services and Solutions
8.10.4 Southwest Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
